• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于接受手术的直径≤2 cm的临床I期肺腺癌,放射组学评分具有预后价值。

Radiomic score is prognostic in clinical stage I lung adenocarcinoma ≤2 cm undergoing surgery.

作者信息

Park Ju Ae, Pham Duy, Wang Hongkun, Khandhar Sandeep, Weyant Michael J, Suzuki Kei

机构信息

Department of Surgery, INOVA Fairfax Medical Center, Fairfax, VA, USA.

University of Virginia School of Medicine, Charlottesville, VA, USA.

出版信息

J Thorac Dis. 2024 Oct 31;16(10):6475-6482. doi: 10.21037/jtd-24-923. Epub 2024 Oct 30.

DOI:10.21037/jtd-24-923
PMID:39552856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11565337/
Abstract

BACKGROUND

As sub-lobar resection becomes acceptable for lung cancer ≤2 cm, a preoperative marker of tumor aggressiveness to choose an appropriate extent of resection becomes necessary. We sought to assess the utility of Computer-Aided Nodule Assessment and Risk Yield (CANARY), a validated radiomic tool, in clinical stage I adenocarcinoma ≤2 cm.

METHODS

We performed a retrospective review of resected lung cancer patients from 2016-2022. Our eligibility criteria included clinical stage I adenocarcinoma, availability of pre-operative computed tomography (CT) imaging, and a lesion size of ≤2 cm. Preoperative imaging was input into the CANARY program, and this was then used to categorize each lesion into good, intermediate, and poor. Kaplan-Meier curve was used to compare the recurrence-free survival (RFS). Descriptive statistics and log-rank tests were conducted to compare RFS between risk groups.

RESULTS

Study population (n=134) had a median age of 68.6 and follow up of 2.9 years. By CANARY profile, 29 patients (21.6%) were good risk, 52 (38.8%) intermediate, and 53 (39.6%) poor. By procedure, 52 patients (38.8%) received wedge resections. Overall, the 3-year RFS was 96.3%, 92.0%, and 72.7% for patients with good, intermediate, and poor risks, respectively. There was a statistically significant difference in RFS between each risk group (χ=12.6, P=0.002). Patients with poor risk were associated with a significantly increased risk of recurrence relative to those with good/intermediate risks [hazard ratio (HR) =5.7, 95% confidence interval (CI): 1.9-17.5].

CONCLUSIONS

Poor risk on CANARY analysis is significantly associated with increased risk of recurrence after resection in clinical stage I adenocarcinoma lesions ≤2 cm.

摘要

背景

随着亚肺叶切除术被认为适用于直径≤2 cm的肺癌,术前选择合适切除范围的肿瘤侵袭性标志物变得必要。我们试图评估经过验证的放射组学工具——计算机辅助结节评估与风险收益(CANARY)在直径≤2 cm的临床I期腺癌中的应用价值。

方法

我们对2016年至2022年接受手术切除的肺癌患者进行了回顾性研究。我们的纳入标准包括临床I期腺癌、术前计算机断层扫描(CT)影像资料以及病灶大小≤2 cm。将术前影像资料输入CANARY程序,然后将每个病灶分为低风险、中风险和高风险。采用Kaplan-Meier曲线比较无复发生存期(RFS)。进行描述性统计和对数秩检验以比较风险组之间的RFS。

结果

研究人群(n = 134)的中位年龄为68.6岁,随访时间为2.9年。根据CANARY分析结果,29例患者(21.6%)为低风险,52例(38.8%)为中风险,53例(39.6%)为高风险。按手术方式,52例患者(38.8%)接受了楔形切除术。总体而言,低风险、中风险和高风险患者的3年RFS分别为96.3%、92.0%和72.7%。各风险组之间的RFS存在统计学显著差异(χ = 12.6,P = 0.002)。与低风险/中风险患者相比,高风险患者的复发风险显著增加[风险比(HR)= 5.7,95%置信区间(CI):1.9 - 17.5]。

结论

在直径≤2 cm的临床I期腺癌病灶中,CANARY分析显示的高风险与切除术后复发风险增加显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d2/11565337/325094c73357/jtd-16-10-6475-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d2/11565337/fd497fefc7a0/jtd-16-10-6475-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d2/11565337/3744ab007c06/jtd-16-10-6475-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d2/11565337/325094c73357/jtd-16-10-6475-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d2/11565337/fd497fefc7a0/jtd-16-10-6475-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d2/11565337/3744ab007c06/jtd-16-10-6475-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d2/11565337/325094c73357/jtd-16-10-6475-f3.jpg

相似文献

1
Radiomic score is prognostic in clinical stage I lung adenocarcinoma ≤2 cm undergoing surgery.对于接受手术的直径≤2 cm的临床I期肺腺癌,放射组学评分具有预后价值。
J Thorac Dis. 2024 Oct 31;16(10):6475-6482. doi: 10.21037/jtd-24-923. Epub 2024 Oct 30.
2
Prognostic implication of consolidation-to-tumor ratio in early lung adenocarcinoma: a retrospective cross-sectional study.早期肺腺癌巩固灶与肿瘤比值的预后意义:一项回顾性横断面研究。
Quant Imaging Med Surg. 2024 May 1;14(5):3366-3380. doi: 10.21037/qims-23-1438. Epub 2024 Apr 26.
3
CTR > 0.7 predicts the subgroup of lung adenocarcinomas ≤ 2 cm at risk of poor outcome treated by sublobar resection compared to lobar resection.CTR>0.7 预测肺腺癌亚组,亚肺叶切除对比肺叶切除治疗的 2cm 以下的肺腺癌,可能存在预后不良的风险。
Cancer Imaging. 2024 Jun 17;24(1):76. doi: 10.1186/s40644-024-00717-4.
4
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.对比解剖性肺段切除术与肺叶切除术治疗临床ⅠA 期肺腺癌的肿瘤学结果:多中心研究中的倾向性评分匹配分析。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):358-64. doi: 10.1016/j.jtcvs.2013.02.008. Epub 2013 Mar 8.
5
A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.联合放射组学特征、临床特征和血清肿瘤标志物预测肺腺癌微乳头/实性成分的可能性。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241249168. doi: 10.1177/17534666241249168.
6
Predicting the recurrence risk factors and clinical outcomes of peripheral pulmonary adenocarcinoma ≤3 cm with wedge resection.预测≤3cm周围型肺腺癌楔形切除术后的复发危险因素及临床结局。
J Cancer Res Clin Oncol. 2017 Jun;143(6):1043-1051. doi: 10.1007/s00432-016-2337-7. Epub 2017 Feb 15.
7
Clinicopathological and computed tomography features associated with recurrence-free survival of patients with small-sized peripheral invasive lung adenocarcinoma after sublobectomy.肺段切除术后小尺寸周围型浸润性肺腺癌患者无复发生存相关的临床病理及计算机断层扫描特征
Quant Imaging Med Surg. 2023 Dec 1;13(12):8144-8156. doi: 10.21037/qims-23-559. Epub 2023 Oct 16.
8
A computed tomography-based score indicative of lung cancer aggression (SILA) predicts lung adenocarcinomas with low malignant potential or vascular invasion.一种基于计算机断层扫描的肺癌侵袭性评分(SILA)可预测低恶性潜能或血管侵犯的肺腺癌。
Cancer Biomark. 2024 May 22:CBM230456. doi: 10.3233/CBM-230456.
9
Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.国家肺癌筛查试验中基于非侵入性计算机断层扫描的肺腺癌风险分层
Am J Respir Crit Care Med. 2015 Sep 15;192(6):737-44. doi: 10.1164/rccm.201503-0443OC.
10
Evaluation of recurrence risk for patients with stage I invasive lung adenocarcinoma manifesting as solid nodules based on F-FDG PET/CT, imaging signs, and clinicopathological features.基于F-FDG PET/CT、影像征象及临床病理特征评估表现为实性结节的Ⅰ期浸润性肺腺癌患者的复发风险
EJNMMI Res. 2023 Jun 1;13(1):52. doi: 10.1186/s13550-023-00998-z.

本文引用的文献

1
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.肺段或亚肺叶切除术治疗外周型ⅠA 期非小细胞肺癌。
N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083.
2
Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis.预测无淋巴结转移的早期肺腺癌(≤3 cm)患者预后的影像组学特征
Diagnostics (Basel). 2022 Aug 6;12(8):1907. doi: 10.3390/diagnostics12081907.
3
Prognostic and predictive value of radiomic signature in stage I lung adenocarcinomas following complete lobectomy.
基于影像组学特征的完全肺叶切除术后 I 期肺腺癌患者的预后及预测价值。
J Transl Med. 2022 Jul 28;20(1):339. doi: 10.1186/s12967-022-03547-9.
4
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.小型周围型非小细胞肺癌的肺段切除术与肺叶切除术比较(JCOG0802/WJOG4607L):一项多中心、开放标签、3期、随机、对照、非劣效性试验
Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3.
5
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.新辅助纳武利尤单抗联合化疗治疗可切除肺癌。
N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11.
6
Computed Tomography-Based Score Indicative of Lung Cancer Aggression (SILA) Predicts the Degree of Histologic Tissue Invasion and Patient Survival in Lung Adenocarcinoma Spectrum.基于计算机断层扫描的肺癌侵袭性评分(SILA)预测肺腺癌谱系中组织学侵袭程度和患者生存。
J Thorac Oncol. 2019 Aug;14(8):1419-1429. doi: 10.1016/j.jtho.2019.04.022. Epub 2019 May 4.
7
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.第八版 AJCC 癌症分期手册:继续从基于人群的方法向更“个体化”的癌症分期方法构建桥梁。
CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17.
8
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.2015 年世界卫生组织肺肿瘤分类:自 2004 年分类以来遗传、临床和放射学进展的影响。
J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630.
9
Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.PET/CT上淋巴结与原发肿瘤SUV的比值可准确预测非小细胞肺癌的淋巴结恶性程度。
Clin Lung Cancer. 2015 Nov;16(6):e253-8. doi: 10.1016/j.cllc.2015.06.001. Epub 2015 Jun 15.
10
Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography.使用定量计算机断层扫描对肺腺癌进行无创风险分层
J Thorac Oncol. 2014 Nov;9(11):1698-703. doi: 10.1097/JTO.0000000000000319.